Blocking the inhibitory receptor programmed cell death 1 prevents allergic immune response and anaphylaxis in mice

被引:7
|
作者
Lama, Jyoti K. [1 ,2 ,3 ,4 ]
Iijima, Koji [5 ,6 ]
Kobayashi, Takao [5 ,6 ]
Kita, Hirohito [1 ,2 ,5 ,6 ]
机构
[1] Mayo Clin, Dept Immunol, Rochester, MN USA
[2] Mayo Clin Arizona, Scottsdale, AZ 85259 USA
[3] Mayo Grad Sch Biomed Sci, Immunol Program, Rochester, MN USA
[4] Mayo Grad Sch Biomed Sci, Immunol Program, Scottsdale, AZ USA
[5] Mayo Clin Arizona, Div Allergy Asthma & Clin Immunol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA
[6] Mayo Clin Arizona, Dept Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA
基金
美国国家卫生研究院;
关键词
Peanut allergy; allergens; Tfh cells; PD-1; IgE; IgG; FOLLICULAR HELPER-CELL; FC-GAMMA-R; T-CELLS; IGE PRODUCTION; FOOD ALLERGY; PD-1; MOUSE; EXPRESSION; SENSITIZATION; DISRUPTION;
D O I
10.1016/j.jaci.2022.01.014
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Food allergy and acute anaphylaxis can be life-threatening. While T follicular helper (Tfh) cells play a pivotal role in the allergic immune responses, the immunologic mechanisms that regulate the production of antibodies (Abs) that mediate anaphylaxis are not fully understood. Objective: The aim of this study was to investigate the role of the inhibitory receptor programmed cell death protein 1 (PD-1), which is highly expressed on Tfh cells, in allergic immune responses using an animal model of peanut allergy and anaphylaxis. Methods: Naive wild-type mice were exposed to peanut flour intranasally and then challenged with peanut extract to induce systemic anaphylaxis. The roles of PD-1 were examined by blocking Abs and using gene-deficient animals. A hapten model and passive cutaneous anaphylaxis were used to characterize allergen-specific Abs. Results: Treatment with anti-PD-1 enhanced development of Tfh cells and germinal center B cells in mice exposed to peanut flour. Nonetheless, anti-PD-1 or its ligand fully protected mice from developing anaphylaxis. Anti-PD-1 treatment or genetic deficiency of PD-1 in CD41 T cells inhibited production of peanut-specific IgE and increased the levels of IgG. The passive cutaneous anaphylaxis showed that peanut-specific Abs generated in anti-PD-1-treated animals prevented, rather than provoked, anaphylaxis when transferred to naive animals. Anti-PD-1 promoted production of Abs with low affinity for an antigen in the hapten model. Conclusion: Blockade of the pathway between PD-1 and its ligand is protective against allergic immune responses. The direct interaction between Tfh cells and B cells may play a pivotal role in controlling Ab quality and clinical manifestation of allergic diseases.
引用
收藏
页码:178 / +
页数:23
相关论文
共 50 条
  • [1] Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor
    Suleman, Muhammad
    Cyprian, Farhan S.
    Jimbo, Steve
    Maina, Teresia
    Prysliak, Tracy
    Windeyer, Claire
    Perez-Casal, Jose
    INFECTION AND IMMUNITY, 2018, 86 (03)
  • [2] Identification of programmed cell death 1 and its ligand in the testicular tissue of mice
    Wang, Li-Ling
    Li, Zhi-Hui
    Duan, Yong-Gang
    Yuan, Shui-Qiao
    Mor, Gil
    Liao, Ai-Hua
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2019, 81 (02)
  • [3] Structure and Interactions of the Human Programmed Cell Death 1 Receptor
    Cheng, Xiaoxiao
    Veverka, Vaclav
    Radhakrishnan, Anand
    Waters, Lorna C.
    Muskett, Frederick W.
    Morgan, Sara H.
    Huo, Jiandong
    Yu, Chao
    Evans, Edward J.
    Leslie, Alasdair J.
    Griffiths, Meryn
    Stubberfield, Colin
    Griffin, Robert
    Henry, Alistair J.
    Jansson, Andreas
    Ladbury, John E.
    Ikemizu, Shinji
    Carr, Mark D.
    Davis, Simon J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (17) : 11771 - 11785
  • [4] The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response
    Luo, Min
    Fu, Liwu
    ONCOTARGET, 2016, 7 (20) : 29794 - 29803
  • [5] Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
    Mallett, Grace
    Laurence, Arian
    Amarnath, Shoba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [6] Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?
    Solinas, Cinzia
    Aiello, Marco
    Rozali, Esdy
    Lambertini, Matteo
    Willard-Gallo, Karen
    Migliori, Edoardo
    TRANSLATIONAL ONCOLOGY, 2020, 13 (10):
  • [7] Programmed cell death ligand-1: A dynamic immune checkpoint in cancer therapy
    Kalim, Muhammad
    Khan, Muhammad Saleem Iqbal
    Zhan, Jinbiao
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (06) : 552 - 566
  • [8] The Role of Programmed Cell Death Receptor 1 in Lung Cancer
    Badiu, Dumitru Cristinel
    Zgura, Anca
    Mehedintu, Claudia
    Haineala, Bogdan
    Anghel, Rodica
    Bacinschi, Xenia
    IN VIVO, 2022, 36 (02): : 1007 - 1012
  • [9] Tumor Progression by Immune Evasion in Melanoma Role of the Programmed Cell Death-1/Programmed Cell Death-1 Ligand 1 Interaction
    Kashani-Sabet, Mohammed
    CANCER, 2010, 116 (07) : 1623 - 1625
  • [10] Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
    Zhang, Chen
    Yang, Qing
    FRONTIERS IN ONCOLOGY, 2021, 10